Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (1.119)

1

Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer

enthalten in: Molecular carcinogenesis | 2024

von Furusawa, T. | Cavero, R. | Liu, Y. | +11

2

Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA) : final overall survival analysis of a phase 3 randomised, placebo-controlled trial

enthalten in: EClinicalMedicine | 2024

von Wu, X. | Zhu, J. | Yin, R. | +33

3

Impact of Drp1-regulated changes in T cell activity on the combined antitumor effects of PARPi and PD-1 inhibitors

enthalten in: International immunopharmacology | 2024

von Ma, J. | Song, J. | Yi, X. | +5

4

A novel SIK2 inhibitor SIC-19 exhibits synthetic lethality with PARP inhibitors in ovarian cancer

enthalten in: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy | 2024

von Wang, F. | Yu, X. | Qian, J. | +9

5

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer : study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial

enthalten in: Trials | 2024

von Belotte, J. | Felicetti, B. | Baines, A. | +7

6

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial

enthalten in: Trials | 2024

von Belotte, J. | Felicetti, B. | Baines, A. | +7

7

Inactivation of VRK1 sensitizes ovarian cancer to PARP inhibition through regulating DNA-PK stability

enthalten in: Experimental cell research | 2024

von Kim, D. | Yun, H. | You, J. | +5

8

"Having cancer is very expensive" : A qualitative study of patients with ovarian cancer and PARP inhibitor treatment

enthalten in: Gynecologic oncology | 2024

von Smith, A. | O'Brien, C. | Haggerty, A. | +2

9

Homologous Recombination Repair Deficiency in Metastatic Prostate Cancer : New Therapeutic Opportunities

enthalten in: International journal of molecular sciences | 2024

von Piombino, C. | Pipitone, S. | Tonni, E. | +13

10

PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response

enthalten in: EBioMedicine | 2024

von Yue, W. | Li, X. | Zhan, X. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[112]